IDO1 inhibitors such as 1-methyl-D, L-tryptophan (1-MT, NLG8189) and navoximod (NLG919), can effectively inhibit IDO enzymes and relieve tumor immunosuppression [25–28]. This evidence concerns the gene IDO1 and neoplasm.